Our results demonstrated that USP53 inhibited proliferation and induced apoptosis of MCF-7 and MDA-MB-231 cells in vivo and in vitro, suggesting that the anti-tumor effect of USP53 was extensive in different subtypes of breast cancer. This evidence concerns the gene USP53 and breast carcinoma.